We report the use of comparative genomic hybridisation (CGH) to define the origin of a supernumerary ring chromosome which conventional cytogenetic banding and fluorescence in situ hybridisation (FISH) (JMed Genet 1998;35:836-840) 
However, when the marker chromosome is very small, or has no significant band landmark, or is present in a low percentage of cells only, even FISH may fail to identify the abnormality. Both FISH and microdissection also depend on good quality metaphases with high mitotic index, conditions that may be difficult to obtain. Therefore, a genome wide screening technique is desirable.
Comparative genomic hybridisation (CGH) is a genome wide screening technique that was first developed to study chromosome abnormalities in tumours. 1-13 It has also been used as an adjunct to conventional cytogenetics for the diagnosis of chromosome imbalance in clinical cytogenetics."'6 However, there are no reports of CGH being used as a tool to diagnose the origin of the extra DNA material in patients who have low percentage mosaicism for a small, supernumerary, marker chromosome.
Here we report a 71 year old woman with mental retardation and a supernumerary marker chromosome, the genetic origin of which was not detected despite attempts using conventional cytogenetics and, latterly, FISH using centromeric probes for a number of chromosomes. In contrast, CGH readily showed its origin from chromosome 19 and complementary experiments firmed the CGH results.
by FISH con-
Materials and methods

CASE REPORT
The proband (fig 1) , a 71 year old woman with mental handicap, had been in residential care for 55 years. No details of her birth history or antenatal life were available. The family recalled her walking at the age of 2 years and the development of speech was delayed until the age of 4 or 5 years. She was not clumsy but always had some difficulty with fine motor skills. She attended a private convent school in early childhood but upon her mother's death, when the proband was aged 16 years, she was received into care and has resided in institutions ever since. The proband was the ninth child born in a family of 10 In the proband's residence, it was assumed that she was affected by Down's syndrome but the true karyotypic abnormality was discovered in 1976 when a blood sample was first submitted for chromosomal analysis. CHROMOSOME PREPARATIONS Metaphase spreads were prepared from phytohaemagglutinin (PHA) stimulated peripheral blood lymphocytes of the patient (for FISH) or healthy males (for CGH studies) using standard procedures of hypotonic treatment and methanol/acetic acid fixation (3:1 v/v).
CGH AND DIGITAL IMAGE ANALYSIS
Genomic DNA probe preparation, labelling procedures, hybridisation, and posthybridisation washings were carried out as described previously. ' Cot-i DNA (Gibco) were cohybridised to normal female metaphase spreads. Hybridisation was allowed to proceed for 48 hours at 37°C in a moist chamber. After posthybridisation washings, images for CGH analysis were acquired using an epifluorescence microscope (Axioplan, Zeiss, Germany) equipped with a cooled CCD camera (Photometrics) controlled by an image analysis system (Digital Scientific, Cambridge, UK). Green, red, and blue fluorescence images were captured from each high intensity, uniformly hybridised metaphase and were analysed as separate grey scale images. The image representing the blue DAPI counterstain was inverted and used for chromosome identification based on its coarse banding pattern. The mean of the individual ratio profiles of 20 metaphase spreads was calculated. For normalisation of the ratio profiles, the model value of the green to red ratio for the entire metaphase was set to 1.0. Finally, the individual ratio profiles were displayed next to the chromosome diagrams. FLUORESCENCE (FIG 2B) CGH was carried out using a DNA sample from the patient. Analysis using a very restrictive threshold with a fluorescence ratio of 0.5-1.5 (which requires 100% abnormal cells to detect any gain or loss of the DNA material) failed to detect any abnormality. Progressively less restrictive thresholds were then used and, surprisingly, a threshold of 0.8-1. 20 40% of the total) showed a gain in DNA material corresponding to 1 9q ( fig 2B) . neither patient has any major congenital malformation, both have moderate mental handicap, but the striking difference is that our elderly patient has reduced stature and proportionately reduced head circumference, whereas the subject of the report of Quack et all'7 has length, weight, and head circumference more than 3 SD above the mean. Quack et all'7 estimated that the IQ of their proband was 69 and reported particular difficulties with language, which is reminiscent of the findings in our patient whose psychological evaluations showed no evidence of a behavioural phenotype and only some evidence of age related gradual decline in intellect. In summary, in three cases non-specific moderate to mild mental retardation or developmental delay has been caused by mosaicism for an abnormal, supernumerary chromosome 19.
So far the approach to determining the origin of cytogenetically unidentifiable chromosomes has involved stepwise FISH using forward painting methods with alpha satellite, single copy, or whole chromosome painting probes, or reverse chromosome painting procedures with either flow sorting or microdissection of the particular chromosome.'" Microdissection followed by DOP-PCR amplification of the dissected DNA is increasingly being used and its modified approaches are reported to be so efficient that just one dissected DNA fragment is sufficient for a successful analysis.9 However, not all diagnostic cytogenetics laboratories have easy access to microdissection technology. Here we present an alternative approach which is not dependent on patient metaphase and is a genome wide screening technique enabling the result to be achieved in just one experiment. Many image analysis systems now in use in cytogenetic laboratories include software for CGH, and results of analysis are available in three working days, which is comparable to the time required for microdissection. Where further confirmation by FISH is necessary one more day is required.
An advantage of CGH over microdissection is that, as shown here, it can provide an estimate of the proportion of cells containing the ring chromosome in the tissue studied. This information is laborious to obtain by chromosome analysis or interphase FISH. The minimum percentage of abnormal cells that can be detected by CGH has not yet been defined, but based on this report and our unpublished data, as little as 15% mosaicism in cultured metaphase cells could be detected. Theoretically, using a medium restrictive fluorescence ratio of 0.75-1.25, there should be at least 50% abnormal cells present for the chromosome imbalance to be detected. '7-29 In the present case, fluorescence ratio 0.8-1.20 was the most restrictive threshold at which the abnormality was detected, which leads to an estimation of the percentage of abnormal cells in uncultured blood of at least 40%. This proportion differs from the result of cytogenetic analysis in cultured cells which is based on a small sample of metaphases obtained from PHA stimulated T lymphocytes, and which showed not more than 28% abnormal cells. We currently use CGH to determine the origin of cytogenetically unidentifiable chromosomes and so far have obtained successful results in 10 cases with different sizes and percentages of ring and marker chromosomes (unpublished data). However, since in CGH the centromeric regions are suppressed, the method would not be applicable to ring or marker chromosomes composed almost entirely of centromeric heterochromatin.
The classical explanation for formation of a centric ring involves breaks in both arms of the chromosome with subsequent fusion of the proximal ends to form a ring and loss of the material distal to the breakpoints. More recently the possibility of U type fusions or a U type fusion in combination with transverse misdivision of the centromere has been put forward as a mechanism for the generation of small ring chromosomes.3" In the case described here, no short arm material could be seen in the ring chromosome either by CGH or by FISH using short arm paint, suggesting a breakpoint at or immediately adjacent to the centromere. No more detailed studies have yet been undertaken to define this breakpoint more precisely. CGH studies indicate that virtually the entire long arm of chromosome 19 is present in the ring, although by FISH the telomeric region is shown not to be present. We have previously shown that partial trisomy or partial monosomy of as little as 4-5 Mb can be detected in telomeric regions by CGH. '6 The fact that CGH has not shown any variation in copy number of any part of 19q suggests that the breakpoint is within 5 Mb of the telomere, and that the loss of long arm material in the formation of the ring chromosome is beyond the resolution of CGH. However, although we have precisely identified the identity of the ring chromosome, we are not able to distinguish the mechanism by which it arose.
The first series of FISH experiments using empirically selected centromeric probes including one for chromosome 19 failed to indicate the origin of microdissection. This may be explained in part by the low percentage of cells containing the ring and difficulties in identifying it with certainty in some mitoses. Also the alpha satellite probe hybridising to chromosomes 1, 5, and 19 was used in the study, since at that time it was the only available centromeric probe for chromosome 19. It is possible that a small change in stringency conditions caused some loss of signal for chromosome 19.
As discussed above, when no cytogenetic or clinical clues are available, a multicolour or stepwise FISH approach with or without chromosome microdissection may be used to identify the origin of a marker chromosome. However, in investigating small marker chromosomes, many service laboratories at present carry out sequential experiments using FISH probes that are selected empirically. Our experience indicates that in FISH studies the empirical approach may not detect a marker that is present in a lower percentage of metaphases, even though it is detected subsequently in a targeted FISH study. Although this experience is unlikely to be a frequent occurrence, it is one that is important for clinical cytogenetic practice.
